GlassScriptPhysician profile
Muhammad Ubaidulhaq
NPI 1265735807
$8,801.07
in general payments reported to CMS, 2019-2025
11 companies · $833 in 2025
The $833 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,604 · 2020: $25.25 · 2021: $908 · 2022: $3,355 · 2023: $1,237 · 2024: $838 · 2025: $833.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,953 · Food and Beverage: $956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,952.66 |
| Food and Beverage | $956.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,164.59 | 2021-2024 | Intellis Adaptivestim, Inceptiv |
| Relievant Medsystems, INC. | $1,951.86 | 2022 | |
| Medtronic USA, INC. | $1,609.12 | 2019-2020 | |
| Abbott Laboratories | $768.06 | 2025 | Proclaim |
| Stryker Corporation | $729.37 | 2022-2024 | Spinejack, Optablate, Autoplex |
| Vertos Medical, INC. | $214.35 | 2021-2023 | Mild Device Kit |
| Boston Scientific Corporation | $159.78 | 2021-2025 | Intracept |
| Spr Therapeutics, INC | $134.72 | 2023-2024 | Sprint Pns System |
| Acacia Pharma INC | $24.82 | 2021 | |
| Saluda Medical Americas, INC. | $24.33 | 2023 | Evoke Scs |
| Nevro Corp. | $20.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Ubaidulhaq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.